Low Concentration Atropine to Slow Myopic Progression in Children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004990

Enrollment

Unknown

Registered

2014-07-03

Start date

2014-07-22

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

two groups:0.01% atropine vs placebo

Eligibility

Sex/Gender

All

Age

8 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age 8-12; Myopia SE: -1D to -6D;Astigmatism: less than 1.5 D; Anisometropia: less than 2 D; BCAV larger than 0.8; IOP less than 21mmHg; Myopia progression more than 0.5 D in one yr.

Exclusion criteria

Exclusion criteria: Ophthalmic diseases other than refractive errors or systematic diseases; Previous use of treatment of atropine, RGP or ortho-k; Allergy or intolerance to atropine or tropicamid.

Design outcomes

Primary

Measure	Time frame
change in refraction;change in axial lengt;	—

Countries

China

Contacts

Public ContactLiu Quan

drliuquan@163.com+86 13808864836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026